Micoli, Francesca
Romano, Maria Rosaria
Carboni, Filippo
Adamo, Roberto
Berti, Francesco
Article History
Received: 22 November 2022
Revised: 24 November 2022
Accepted: 9 January 2023
First Online: 18 January 2023
Declarations
:
: All the authors are employees of the GSK group of companies.
: Synflorix is a trademark of the GSK group of companies. Prevnar and Prevnar13 are trademarks of Wyeth LLC. Pneumosil is a trademark of Serum Institute of India Private Limited.